Skip to main content

Table 1 Clinical data of 33 patients with intrathoracic anastomotic leak

From: Choice of therapeutic strategies in intrathoracic anastomotic leak following esophagectomy

 

Group

P-value

Contained leak

Uncontained leak

Number of patients (n)

15

18

 

Age (years)

56.2 ± 11.0

64.8 ± 6.6

0.01* (t-test)

Gender (n)

  

0.18

  Male

10

14

 

  Female

5

4

 

Tumor location (n)

  

0.6

  Upper third

0

1

 

  Middle third

9

9

 

  Lower third/GEJ

6

8

 

Tumor type (n)

  

0.01* (χ2 test)

  SCC

12

15

 

  ADC

3

2

 

Neoadjuvant therapy (n)

  

0.64

  None

14

16

 

  CT

1

1

 

  RT

0

1

 

TNM stage (n)

  

0.23

  I

4

1

 

  II

6

7

 

  III

5

9

 

Subgroup (n)

  

0.77

  Early leak

5

11

 

  Late leak

10

7

 

Interval of diagnosis of leak (days)

12.6 ± 8.9

6.9 ± 3.9

0.019* (t-test)

Treatment of leak (n)

   

  Conservative

11

9

 

  Surgical exploration

4

9

 

Outcome of treatment (n)

  

0.118

  Cured patients

14

12

 

  Hospital mortality

1

6 (1 died of heart failure)

 
  1. *P < 0.05. ADC adenocarcinoma; CT, chemotherapy; GEJ, gastroesophageal junction; RT radiotherapy; SCC squamous cell carcinoma.